Massive liver transplant study aims to predict bleeding and save lives
NCT ID NCT06257407
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will follow 1,200 liver transplant patients in France to understand why some people bleed heavily during surgery while others don't. Researchers will use advanced methods like machine learning to build better prediction tools. The goal is to help doctors manage bleeding more effectively and reduce the need for blood transfusions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could lead to better prediction tools for bleeding during liver transplants, helping doctors reduce unnecessary transfusions and improve patient safety.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly change patient care. Results may not apply to all hospitals or patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANT; COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Claude Huriez
RECRUITINGLille, France
Contact
-
CHU Estaing
NOT_YET_RECRUITINGClermont, France
Contact
-
CHU Grenoble Alpes
NOT_YET_RECRUITINGGrenoble, France
Contact
-
CHU Haut Levêque
NOT_YET_RECRUITINGPessac, France
Contact
-
CHU Hautepierre
NOT_YET_RECRUITINGStrasbourg, France
Contact
-
CHU La Timone
NOT_YET_RECRUITINGMarseille, France
Contact
-
CHU Pitié-Salpêtrière
NOT_YET_RECRUITINGParis, France
Contact
-
CHU Pontchaillou
NOT_YET_RECRUITINGRennes, France
Contact
-
CHU Toulouse Rangueil
NOT_YET_RECRUITINGToulouse, France
Contact
-
CHU Tours
NOT_YET_RECRUITINGTours, France
Contact
-
Chru Minjoz
RECRUITINGBesançon, France
Contact
-
Hôpital Beaujon
NOT_YET_RECRUITINGClichy, France
Contact
-
Hôpital De L'Archet 2
NOT_YET_RECRUITINGNice, France
Contact
-
Hôpital Paul Brousse
RECRUITINGVillejuif, France
Contact
-
Hôpital St Eloi
NOT_YET_RECRUITINGMontpellier, France
Contact
-
Hôpital de la Croix-Rousse
RECRUITINGLyon, France
Contact